Detalles de la búsqueda
1.
Novel strategy of rapid typing of Shiga toxin-producing Escherichia coli using MALDI Biotyper and ClinProTools analysis.
J Infect Chemother
; 27(8): 1137-1142, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33745812
2.
Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers.
Cephalalgia
; 39(1): 100-110, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29783863
3.
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Circulation
; 132(1): 27-39, 2015 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26059012
4.
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
N Engl J Med
; 367(26): 2482-94, 2012 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23121374
5.
Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality.
Pharmacoepidemiol Drug Saf
; 24(7): 738-47, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26011775
6.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(3): 242-51, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25851955
7.
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial.
Nephrol Dial Transplant
; 27(7): 2872-9, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22529163
8.
Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.
Nephron Clin Pract
; 121(3-4): c124-30, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23208191
9.
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.
Pharm Stat
; 14(4): 368, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26096896
10.
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis.
Am J Kidney Dis
; 53(2): 197-207, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19110359
11.
Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events.
Med Decis Making
; 36(8): 965-72, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26987347
12.
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
Clin J Am Soc Nephrol
; 10(5): 800-7, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25887067
13.
Spread of OXA-23-producing Acinetobacter baumannii ST2 and ST246 in a hospital in Japan.
J Med Microbiol
; 64(7): 739-744, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25934553
14.
The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Clin J Am Soc Nephrol
; 10(5): 791-9, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25710802
15.
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.
J Am Heart Assoc
; 3(6): e001363, 2014 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25404192
Resultados
1 -
15
de 15
1
Próxima >
>>